Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 28: 59-62, 1982;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fruchart, J. C.
Right arrow Articles by Moschetto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruchart, J. C.
Right arrow Articles by Moschetto, Y.

Clinical Chemistry, Vol 28, 59-62, Copyright © 1982 by American Association for Clinical Chemistry

Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay

JC Fruchart, I Kora, C Cachera, V Clavey, P Duthilleul and Y Moschetto

We describe a simplified electroimmunoassay for quantification of human apolipoproteins A-I and B on prepared plates. A solution of agarose at 55 degrees C, containing hydroxyethylcellulose and antibodies, is poured onto a plastic film and allowed to gel. Wells are punched in the gels and the plates are dried for storage. Before use, they are rehydrated and buffered. We use succinylated Sudan Black to prestain lipoprotein fractions of plasma. After electrophoresing samples of plasma or standards for 3 h at 4 degrees C at 12.5 V/cm, we measure the peak heights and read the results from a standard curve prepared by using calibrated sera of known apolipoprotein B and A-I content as secondary standard. The within- and between-assay coefficients of variation were less than 4% in all cases. Results correlated well with those obtained by classic electroimmunodiffusion. Subjects with confirmed atherosclerotic lesions had significantly (p less than 10(- 9)) lower ratios of apolipoprotein A-I to apolipoprotein B, compared with ratios in controls.


The following articles in journals at HighWire Press have cited this article:


Home page
 Eur Heart JHome page
D. E. Laaksonen, L. Niskanen, K. Nyyssonen, T. A. Lakka, J. A. Laukkanen, and J. T. Salonen
Dyslipidaemia as a predictor of hypertension in middle-aged men
Eur. Heart J., October 2, 2008; 29(20): 2561 - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Beghin, N. Duhal, P. Poulain, P. Hauw, B. Lacroix, J.-M. Lecerf, J.-P. Bonte, J.-C. Fruchart, and G. Luc
Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry
J. Lipid Res., July 1, 2000; 41(7): 1172 - 1176.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Mykkanen, J. Kuusisto, S. M. Haffner, M. Laakso, and M. A. Austin
LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2742 - 2748.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
L.C.J.M. Lemaire, T. van der Poll, J.J.B. van Lanschot, H.M. Levels, B. van der Ende, S.J.H. van Deventer, and D.J. Gouma
Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines
Innate Immunity, October 1, 1997; 4(5): 331 - 338.
[Abstract] [PDF]

Home page
 StrokeHome page
L. Niskanen, R. Rauramaa, H. Miettinen, S. M. Haffner, M. Mercuri, and M. Uusitupa
Carotid Artery Intima-Media Thickness in Elderly Patients With NIDDM and in Nondiabetic Subjects
Stroke, November 1, 1996; 27(11): 1986 - 1992.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Kuusisto, L. Mykkanen, K. Kervinen, Y. A. Kesaniemi, and M. Laakso
Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects
Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1280 - 1286.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.